1. Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts.
- Author
-
Khosousi S, Sturchio A, Appleton E, Paslawski W, Ta M, Nalls M, Singleton AB, Iwaki H, and Svenningsson P
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Cohort Studies, Biomarkers cerebrospinal fluid, Tropanes, Parkinson Disease cerebrospinal fluid, Parkinson Disease diagnostic imaging, Parkinson Disease metabolism, Tomography, Emission-Computed, Single-Photon methods, Dopamine Plasma Membrane Transport Proteins metabolism, Dopa Decarboxylase metabolism
- Abstract
Background: Recent studies identified increased cerebrospinal fluid (CSF) DOPA decarboxylase (DDC) as a promising biomarker for parkinsonian disorders, suggesting a compensation to dying dopaminergic neurons. A correlation with 123I-FP-CIT-SPECT (DaT-SPECT) imaging could shed light on this link., Objective: The objective is to assess the relationship between CSF DDC levels and DaT-SPECT binding values., Methods: A total of 51 and 72 Parkinson's disease (PD) subjects with available DaT-SPECT and CSF DDC levels were selected from the PPMI and Biopark cohorts, respectively. DDC levels were analyzed using proximity extension assay and correlated with DaT-SPECT striatal binding ratios (SBR). All analyses were corrected for age and sex., Results: CSF DDC levels in PD patients correlated negatively with DaT-SPECT SBR in both putamen and caudate nucleus. Additionally, SBR decreased with increased DDC levels over time in PD patients., Conclusion: CSF DDC levels negatively correlate with DaT-SPECT SBR in levodopa-treated PD. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society., (© 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.)
- Published
- 2024
- Full Text
- View/download PDF